Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Aprea Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q3 2025
- Shares held
- 1.70M
- +76.7K (+4.7%) vs. Q3 2025
- Total value
- $1.45M
- −$941.5K (−39.4%) vs. Q3 2025
- New holders
- 5
- 5 more added
- Sold out
- 6
- 6 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 370,541 | $316.1K | 0.09% | −168,759−31.3% | Reduced |
| Murchinson Ltd. | 340,139 | $290.1K | 0.16% | +340,139 | New |
| Sphera Funds Management Ltd. | 270,000 | $230.3K | 0.05% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 205,760 | $175.5K | 0.01% | 00.0% | Unchanged |
| DRW Securities, LLC | 120,651 | $102.9K | 0.01% | +120,651 | New |
| Morgan Stanley | 77,030 | $65.7K | 0.00% | +11,222+17.1% | Added |
| Vanguard Group Inc | 58,086 | $49.5K | 0.00% | −100,152−63.3% | Reduced |
| Citadel Advisors LLC | 51,041 | $43.5K | 0.00% | +51,041 | New |
| Jane Street Group, LLC | 46,621 | $39.8K | 0.00% | +46,621 | New |
| Geode Capital Management, LLC | 40,950 | $34.9K | 0.00% | −3,666−8.2% | Reduced |
| BNP Paribas Arbitrage, SA | 27,332 | $23.3K | 0.00% | +10,200+59.5% | Added |
| LPL Financial LLC | 26,052 | $22.2K | 0.00% | +10,000+62.3% | Added |
| XTX Topco Ltd | 24,304 | $20.7K | 0.00% | +24,304 | New |
| HighTower Advisors, LLC | 13,864 | $11.8K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 8,504 | $7.25K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,827 | $6.68K | 0.00% | +7,259+1,278.0% | Added |
| Bank of America Corp | 3,299 | $2.81K | 0.00% | −1,562−32.1% | Reduced |
| UBS Group AG | 2,461 | $2.10K | 0.00% | +2,458+81,933.3% | Added |
| Group One Trading, L.P. | 577 | $492 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $255 | 0.00% | −100−25.0% | Reduced |
| WealthCollab, LLC | 158 | $135 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 15 | $13 | 0.00% | −27−64.3% | Reduced |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −137,174−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −112,223−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,264−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −10,496−100.0% | Sold out |
| MB, Levis & Associates, LLC | 0 | $0 | 0.00% | −806−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |